NovaGo Therapeutics
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
NovaGo Therapeutics has raised €35M across 2 funding rounds from 7 investors, most recently a Series B round in Sep 2026. Based in Schlieren, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Schlieren, Switzerlandwww.novagotherapeutics.com ↗
Total raised
€35M
€34,785,113
Funding rounds
2
Investors
7
distinct backers
Active since
2019-01
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDNovaGo Therapeutics — funding by year — interactive chart.
Data table
| NovaGo Therapeutics — funding by year | |
|---|---|
| 2018 | €8.9M |
| 2026 | €26M |
Signals
High confidenceRaise-next likelihood23
base rate 48% for Series B
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 8y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-02 | Series B | €26M | Existing investors,Neurimmune Holding,new investors,Pureos Ventures,Swiss Paraplegic Foundation,Wings for Life | View deal → |
| 2019-01-01 | Series A | €8.9M | Neurimmune Holding,Pureos Bioventures | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData